- Citations, last 5 years
- 2 490
- Works, last 5 years
- 440
- h-index
- 112
- Scientists listed
- 28
- Grants since 2016
- 3 213
Grants received
2020–2025 · research · R37
Investigating HIF1-alpha Signaling to Identify Predictive Markers and Therapeutic Targets in Desmoid-Type Fibromatosis
Aimee Marie Crago · Kettering University · funded by National Institutes of Health
2020–2025 · research · R35
Investigating histone glycation as a new dynamic epigenetic mark
Yael E David-Shternberg · Kettering University · funded by National Institutes of Health
2020–2025 · research · R01
A personalized approach using hypoxia resolution to guide curative-intent radiation dose reduction to 30 Gy: A novel de-escalation paradigm for HPV-associated oropharynx cancers
Nancy Y Lee · Kettering University · funded by National Institutes of Health
2020–2025 · program · P50
MSK SPORE in Genomic Instability in Breast Cancer
Simon N. Powell · Kettering University · funded by National Institutes of Health
2020–2025 · research · R01
Lipid Droplets and Transcriptional Regulation of Metabolism
Robert V Farese · Kettering University · funded by National Institutes of Health
2020–2024 · research · R01
Determining the risk factor profile and biology of colorectal cancer in Nigeria
Olusegun Isaac Alatise · Kettering University · funded by National Institutes of Health
2020–2023 · research · R01
Investigating Amino Acid Depletion in the Tumor Microenvironment as a Metabolic Immune Checkpoint
Craig B Thompson · Kettering University · funded by National Institutes of Health
2020–2025 · cooperative agreement · U01
Improving Outcome in Patients with Advanced Intrahepatic Cholangiocarcinoma: A Randomized Phase II Study of Gemcitabine and Oxaliplatin With or Without Regional Floxuridine (FUDR)
Andrea Cercek · Kettering University · funded by National Institutes of Health
2020–2021 · research · R21
Manipulating autophagy in human neurons to determine subtype-specific neurodegenerative disease phenotypes
Lorenz P. Studer · Kettering University · funded by National Institutes of Health
2020–2024 · research · R00
Uncovering Roles of Metabolites in Colorectal Cancer Etiology
Xiang Shu · Kettering University · funded by National Institutes of Health
2020–2025 · research · R01
Ultrasmall particle-based solutions for inducing ferroptosis and improving anti-tumor immune responses in cancer
Michelle S Bradbury · Kettering University · funded by National Institutes of Health
2020–2025 · research · R01
Effect and Mechanism of Acupuncture for Cancer-related Cognitive Impairment (ENHANCE)
Jun J Mao · Kettering University · funded by National Institutes of Health
2020–2025 · career development · K08
Investigating altered T-cell metabolism during chronic antigen encounter
Santosha Vardhana · Kettering University · funded by National Institutes of Health
2020–2025 · research · R01
Rapid motion-robust quantitative DCE-MRI for the assessment of gynecologic cancers
Ricardo Otazo · Kettering University · funded by National Institutes of Health
2020–2024 · research · R01
Mentoring a Nigerian junior investigator with a mixed-methods analysis of barriers to colorectal cancer presentation in Nigeria
Olusegun Isaac Alatise · Kettering University · funded by National Institutes of Health
2020–2025 · research · R01
Epiproteomics of Sezary Syndrome
Kojo S. J. Elenitoba-Johnson · Kettering University · funded by National Institutes of Health
2020–2025 · cooperative agreement · U01
Evaluation of the effect of patient-context factors and sample acquisition on the quality and analytical performance of cell-free DNA and circulating tumor cells profiling assays in prostate cancer pa
Maria E Arcila · Kettering University · funded by National Institutes of Health
2020–2025 · research · R01
Rapid motion-robust quantitative DCE-MRI for the assessment of gynecologic cancers
Oguz Akin · Kettering University · funded by National Institutes of Health
2020–2022 · fellowship · F31
Defining the biological consequences of somatic mutations in high risk AML using integrative single cell approaches
Maria Sirenko · Kettering University · funded by National Institutes of Health
2020–2025 · career development · K08
Exploring the combinatorial efficacy between chemotherapy and T cell checkpoint inhibition and the role of cellular senescence
Matthew J Bott · Kettering University · funded by National Institutes of Health
2020–2025 · research · R37
Metabolic control of normal and malignant hematopoiesis
Andrew Michael Intlekofer · Kettering University · funded by National Institutes of Health
2020–2025 · career development · K08
Investigating altered T-cell metabolism during chronic antigen encounter
Santosha Vardhana · Kettering University · funded by National Institutes of Health
2020–2025 · research · R01
A Randomized Controlled Trial of Emotion Regulation Therapy for Cancer Caregivers: A Mechanism-Targeted Approach to Addressing Caregiver Distress
Allison Applebaum · Kettering University · funded by National Institutes of Health
2020–2025 · research · R01
A personalized approach using hypoxia resolution to guide curative-intent radiation dose reduction to 30 Gy: A novel de-escalation paradigm for HPV-associated oropharynx cancers
Nancy Y Lee · Kettering University · funded by National Institutes of Health
2020–2026 · career development · K08
Exploring the combinatorial efficacy between chemotherapy and T cell checkpoint inhibition and the role of cellular senescence
Matthew J Bott · Kettering University · funded by National Institutes of Health
2020–2025 · research · R01
Ontogeny and Function of Tumor-Resident Innate Lymphocytes and Innate-Like T Cells
Ming Li · Kettering University · funded by National Institutes of Health
2020–2024 · research · R01
Development of large-field-of-view hyperpolarized MRI
Charles H. Cunningham · Kettering University · funded by National Institutes of Health
2020–2027 · research · R35
The TGFÃÂÃÂÃÂò Signaling Pathway in Development and Cancer
Joan Massague · Kettering University · funded by National Institutes of Health
2020–2025 · cooperative agreement · U01
Comparative Modeling of Effective Policies for Colorectal Cancer Control
Amy Knudsen · Kettering University · funded by National Institutes of Health
2020–2027 · research · R35
Understanding and Mimicking TCR Recognition with Therapeutic Monoclonal Antibodies.
David A Scheinberg · Kettering University · funded by National Institutes of Health
2020–2025 · research · R35
Investigating histone glycation as a new dynamic epigenetic mark
Yael E David-Shternberg · Kettering University · funded by National Institutes of Health
2020–2025 · career development · K08
Exploring the combinatorial efficacy between chemotherapy and T cell checkpoint inhibition and the role of cellular senescence
Matthew J Bott · Kettering University · funded by National Institutes of Health
2020–2022 · fellowship · F99
Development of senolytic CAR T cells as new therapeutic agents
Corina Amor Vegas · Kettering University · funded by National Institutes of Health
2020–2025 · research · R01
Defining the impact of mutant oncogene zygosity
Sarat Chandarlapaty · Kettering University · funded by National Institutes of Health
2020–2024 · research · R01
Collecting whole genome sequence data to enhance the value of the first multi-center study of colorectal cancer risk factors and biology in Nigeria
Olusegun Isaac Alatise · Kettering University · funded by National Institutes of Health
2020–2025 · research · R37
A Randomized Trial to Minimize Non-Response to Aerobic Training in Operable Breast Cancer
Jessica Scott · Kettering University · funded by National Institutes of Health
2020–2026 · research · R01
Clinical Qualification of Imaging and Fluid-Based Tumor Monitoring Biomarkers for Metastatic Castration Resistant Prostate Cancer
Michael J Morris · Kettering University · funded by National Institutes of Health
2020–2025 · research · R37
Diversity Supplement to Expansion of Tumoroid Models for Precise Treatment of the Rectal Cancer Patient
Jesse Joshua Smith · Kettering University · funded by National Institutes of Health
2020–2024 · career development · K08
Multi-antigen-specific CAR T cells to treat acute myeloid leukemia
Scott E James · Kettering University · funded by National Institutes of Health
2020–2025 · cooperative agreement · U01
Evaluation of the effect of patient-context factors and sample acquisition on the quality and analytical performance of cell-free DNA and circulating tumor cells profiling assays in prostate cancer pa
Maria E Arcila · Kettering University · funded by National Institutes of Health